Mackenzie Financial Corp Artivion, Inc. Transaction History

Mackenzie Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$16.7 - $21.63 $169,404 - $219,414	10,144 New	10,144 $214,000
Q4 2018 Feb 06, 2019	SELL	$25.76 - $34.03 $871,563 - $1.15 Million	-33,834 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$28.6 - $35.75 $204,947 - $256,184	-7,166 Reduced 17.48%	33,834 $1.19 Million
Q2 2018 Aug 13, 2018	BUY	$19.4 - $29.35 $223,041 - $337,436	11,497 Added 38.97%	41,000 $1.14 Million
Q1 2018 May 14, 2018	BUY	$16.85 - $22.1 $84,485 - $110,809	5,014 Added 20.47%	29,503 $592,000
Q4 2017 Feb 13, 2018	BUY	$18.65 - $23.85 $136,089 - $174,033	7,297 Added 42.44%	24,489 $469,000
Q3 2017 Nov 13, 2017	BUY	$18.85 - $23.05 $46,559 - $56,933	2,470 Added 16.78%	17,192 $390,000
Q2 2017 Aug 14, 2017	BUY	N/A	14,722	14,722 $294,000

179

36.1M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.25B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.